In a separate study by Liu et al., the prognostic utility of LINE-1 hypomethylation combined with RASSF1A gene hypermethylation in sera was evaluated for predicting early recurrence post-curative surgery in HCC patients. This evidence concerns the gene RASSF1 and hepatocellular carcinoma.